1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ESPERION THERAPEUTICS INC.
Esperion Therapeutics Inc.
XNAS: ESPR
Download real time
2.40 -0.07 (-2.83%)
42.58% Fall from 52W High
2.8M
XNAS Volume

XNAS 13 Mar, 2026 1:33 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Esperion Therapeutics Inc is scheduled for today, for the purpose of Esperion Therapeutics Inc Annual Report for 2025 See details

Esperion Therapeutics Inc - ESPR - stock price prediction, stock price target, analyst ratings from 7 analysts

Esperion Therapeutics Inc has a share price target of US$ 7, revenue growth forecast of 21.0%, and profit growth estimate of 79.8% for FY25, based on top 7 analyst calls.

Forecaster Screeners